Home > Insider Trading > Filing (0001567619-15-001060)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641489	Vtv Therapeutics Inc.	VTVT	Pharmaceutical Preparations (2834)	473916571

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1186472	O Ronald Perelman	C/O Macandrews &Amp; Forbes Incorporated 35 East 62Nd Street New York NY 10065		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2015-08-04	40,000	$10.00	1,706,666	No	4	P	Indirect	See footnote.
Class A Common Stock	Acquisiton	2015-08-04	30,000	$10.00	1,736,666	No	4	P	Indirect	See footnote.
Class A Common Stock	Acquisiton	2015-08-05	30,000	$10.00	1,766,666	No	4	P	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote.
No	4	P	Indirect	See footnote.
No	4	P	Indirect	See footnote.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.99 to $10.05, inclusive, on August 3, 2015, prior to the closing of the Issuer's initial public offering. The reporting person undertakes to provide to vTv Therapeutics Inc., any security holder of vTv Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnotes 1 and 3 to this Form 4.
Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"), which holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC and M&F Group may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of vTv Therapeutics Holdings LLC, an indirect subsidiary of M&F Inc. ("Holdings"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and Holdings.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.00, inclusive.